Ignite Creation Date:
2024-05-06 @ 8:23 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06363708
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-12
First Post:
2024-04-09
Brief Title:
Tislelizumab in Combination With Chemotherapy as a Neoadjuvant Treatment for Advanced Endometrial Cancer
Sponsor:
Zhongnan Hospital
Organization:
Zhongnan Hospital
Organization Data
Organization:
Zhongnan Hospital
Class:
OTHER
Study ID:
2024050
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Zhongnan Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None